MAP2K7 and melanoma: For example, in the elegant work of Kwong et al., it was shown that in NRAS-mutant melanomas, pharmacological inhibition of MEK could drive to apoptosis but not cell-cycle arrest, as it would happen after the abrogation of NRAS activity.